-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"I am very fortunate to be a beneficiary of DragonFly™ and entrust my life to the team of Professor Wang Jian'an of Zhejiang Second Hospital and De Nuo Medical.
I am very relieved and proud
.
" This seventy-year-old man is a founding investor of De Nuo Medical.
On April 15, 2021, Professor Wang Jianan's team from the Second Affiliated Hospital of Zhejiang University School of Medicine used Dejin Medical's DragonFly™ mitral valve clamp system to complete mitral valve repair surgery for a 71-year-old patient with dilated cardiomyopathy
.
The patient had paroxysmal chest pain 2 months ago, accompanied by dyspnea, and was admitted to the hospital after poor medication and implant pacing
Before the operation, the team of Professor Wang Jian'an from Zhejiang Second Hospital, Professor Scott Lim from the University of Virginia Medical Center and Professor Lin Yixian from the Hong Kong Asia-Pacific Medical Center conducted a rigorous preoperative evaluation of the patient.
The patient’s left heart failure was severe and extremely risky, and the expert team agreed.
It is believed that the use of DragonFly™ mitral valve clamp system for mitral valve edge-to-edge repair is the best choice for patients
.
At the same time, patients and their families are also confident in Deno Medical's products
"To be honest, I have been worried about products that are still in the clinical stage.
Friends around me also have doubts about new technologies.
They persuaded me to consider other treatments, such as the mature product Mitraclip from the American company
.
But I believe in Deno.
In the face of this heavy trust, the Dejin Medical Mitral Valve Team has been more moved behind the seriousness it has always done
.
"After receiving this task, my first feeling was moved and proud.
DragonFly™ does not bear heavy burdens, the operation process is smooth, the patient's reflux is reduced immediately during the operation, and the patient will recover and be discharged 4 days after the operation.
This is the greatest affirmation of the safety of the DragonFly™ device and the team's efforts
.
In an exchange before being discharged from the hospital, the health department and life support, the patient also said: "Thank you for the efforts of Professor Wang Jian’an and the Dejin team.
I believe that in the near future, there will be more people accepting new technologies.
Concept, there will be more mitral regurgitation patients like me who will be treated.
Thank you for bringing us new hope
.
"
Guarding the heart, practicing innovation, Dejin Medical does not forget its original aspiration and fulfills its trust.
